Full Name
Kon Oi Lian
(not current staff)
Variants
Oi, L.K.
Kon, O.-L.
KON, OI-LIAN
Kon, O.L.
 
Main Affiliation
 
 
Email
bchkonol@nus.edu.sg
 
 

Results 21-38 of 38 (Search time: 0.006 seconds).

Issue DateTitleAuthor(s)
212002Human liver-derived cells stably modified for regulated proinsulin secretion function as bioimplants in vivoChen, X.; Patil, J.G.; Lok, S.H.L.; Kon, O.L. 
221996Improvements on the purification of mannan-binding lectin and demonstration of its Ca2+-independent association with a C1s-like serine proteaseTan, S.M. ; Chung, M.C.M. ; Kon, O.L. ; Lu, J. ; Lee, S.H. ; Thiel, S.
23Jan-1994In vitro cytotoxic properties of gold(I) and platinum(II) compounds containing asymmetric [2-(methylsulfinyl) ethyl]diphenylarsine and its phosphorus analogue.Chooi, S.Y.M. ; Leung, P.-H. ; Sim, K.Y. ; Tan, K.S.; Kon, O.L. 
4May-2010Insulin expressed from endogenously active glucose-responsive EGR1 promoter in bone marrow mesenchymal stromal cells as diabetes therapyChen, N.K.F.; Tan, S.Y.; Udolph, G.; Kon, O.L. 
515-Jun-2008Integrative genomics identifies RAB23 as an invasion mediator gene in diffuse-type gastric cancerHou, Q.; Yong, H.W.; Grabsch, H.; Zhu, Y.; Siew, H.L.; Ganesan, K.; Cross, D.; Lay, K.T.; Tao, J.; Gopalakrishnan, V.; Bor, L.T. ; Oi, L.K. ; Tan, P. 
62014Intragenic integration in DLC1 sustains factor VIII expression in primary human cells without insertional oncogenicitySivalingam, J.; Phan, T.T.; Kon, O.L. 
71-Mar-2016Multidimensional Genome-wide Analyses Show Accurate FVIII Integration by ZFN in Primary Human CellsSivalingam, Jaichandran; Kenanov, Dimitar; Han, Hao; Nirmal, Ajit Johnson; Ng, Wai Har; Lee, Sze Sing; Masilamani, Jeyakumar; TOAN THANG PHAN; Maurer-Stroh, Sebastian; Kon, O.L. 
810-Dec-1987Murine antiestrogen-binding protein: Characterization, solubilization and modulation by lipidsMatin, A.; Hwang, P.L.H. ; Kon, O.L. 
91999Naked Plasmid-Mediated Gene Transfer to Skeletal Muscle Ameliorates Diabetes MellitusKon, O.L. ; Sivakumar, S.; Teoh, K.L.; Lok, S.H.L.; Long, Y.C.
10May-2013Negative regulatory responses to metabolically triggered inflammation impair renal epithelial immunity in diabetes mellitusChen, N.K.F.; Chong, T.W.; Loh, H.-L.; Lim, K.H.; Gan, V.H.L.; Wang, M.; Kon, O.L. 
1112-May-1997Purification and binding properties of a human ficolin-like proteinLe, Y.; Tan, S.M. ; Lee, S.H.; Kon, O.L. ; Lu, J. 
12May-1996Screening of traditional medicines for their inhibitory activity against HIV-1 proteaseXu, H.-X. ; Wan, M.; Loh, B.-N.; Kon, O.-L. ; Chow, P.-W. ; Sim, K.-Y. 
131993Selective antiproliferative effects of thymidineOoi, S.O.; Sim, K.Y.; Chung, M.C.M. ; Kon, O.L. 
142016ST3GAL1-Associated Transcriptomic Program in Glioblastoma Tumor Growth, Invasion, and PrognosisChong Y.K.; Sandanaraj E.; Koh L.W.H.; Thangaveloo M.; Tan M.S.Y.; Koh G.R.H.; Toh T.B. ; Lim G.G.Y.; Holbrook J.D. ; Kon O.L. ; Nadarajah M.; Ng I. ; Ng W.H. ; Tan N.S. ; Lim K.L. ; Tang Soo Leng Carol ; Ang B.T. 
151998Stable expression of human α-2,6-sialyltransferase in Chinese hamster ovary cells: Functional consequences for human erythropoietin expression and bioactivityZhang, X. ; Lok, S.H.L.; Kon, O.L. 
161992Synthesis of 2-(p-chlorobenzyl)-3-aryl-6-methoxybenzofurans as selective ligands for antiestrogen-binding sites. Effects on cell proliferation and cholesterol synthesisTeo, C.C.; Kon, O.L. ; Sim, K.Y. ; Ng, S.C. 
171997Synthesis of 3-(p-Halobenzyl)-4-aryl-2H-chromenes as Selective Ligands for Antiestrogen-binding SitesSrikanth, N.; Kon, O.-L. ; Ng, S.-C. ; Sim, K.-Y. 
181-Jan-2005Wavelet transformations of tumor expression profiles reveals a pervasive genome-wide imprinting of aneuploidy on the cancer transcriptomeAggarwal, A.; Leong, S.H.; Lee, C.; Kon, O.L. ; Tan, P.